Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study

Conflicting results are available regarding the influence of ACEi/ARBs on the risk of COVID-19 infection, while less is known about their impact on the clinical outcome of patients with STEMI diagnosed with COVID-19. Our aim was to evaluate the impact of ACEi/ARBs therapy on in-hospital mortality an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Lucia Barbieri, Daniela Trabattoni, Giulio G. Stefanini, Enrico Vizzardi, Gabriele Tumminello, Emilio Assanelli, Marianna Adamo, Carlo A. Pivato, Giovanni Provenzale, Domitilla Gentile, Marco Metra, Stefano Carugo
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2021-12-01
Σειρά:	Frontiers in Cardiovascular Medicine
Θέματα:	STEMI patients COVID-19 RAAS inhibitors mortality outcome
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.792804/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!